We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current IDYA market cap is 2.43B. The company's latest EPS is USD -1.3069 and P/E is -21.46.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.04M | 3.92M | 0 | 0 | 0 |
| Operating Income | -33.52M | -41.92M | -51.02M | -64.93M | -66.89M |
| Net Income | -27.44M | -33.96M | -39.57M | -52.77M | -51.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 19.54M | 27.94M | 50.93M | 23.39M |
| Operating Income | -44.27M | -35.34M | -50.27M | -62.5M | -134.43M |
| Net Income | -41.98M | -34.5M | -49.76M | -58.66M | -112.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 532.94M | 649.32M | 961.53M | 973.66M | 1.24B |
| Total Liabilities | 24.89M | 28.23M | 26.22M | 42.01M | 59.46M |
| Total Equity | 508.05M | 621.09M | 935.31M | 931.66M | 1.18B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 113M | 298.27M | 381.35M | 387.97M | 649.32M |
| Total Liabilities | 12.6M | 100M | 79.83M | 38.51M | 28.23M |
| Total Equity | 100.4M | 198.27M | 301.51M | 349.46M | 621.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -91.48M | -115.22M | -43.81M | -76.7M | -125.93M |
| Investing | -46.51M | -158.46M | -353.97M | -285.41M | -305.45M |
| Financing | 221.82M | 362.72M | 349.11M | 388.29M | 674.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.31M | 55.46M | -55.78M | -87.18M | -115.22M |
| Investing | 2.27M | -146.24M | -69.67M | -33.4M | -158.46M |
| Financing | 50.61M | 128.75M | 145.45M | 97.17M | 362.72M |
| Market Cap | 2.43B |
| Price to Earnings Ratio | -21.46 |
| Price to Sales Ratio | 103.62 |
| Price to Cash Ratio | 15.43 |
| Price to Book Ratio | 3.9 |
| Dividend Yield | - |
| Shares Outstanding | 86.43M |
| Average Volume (1 week) | 798.8k |
| Average Volume (1 Month) | 1.05M |
| 52 Week Change | -11.01% |
| 52 Week High | 47.735 |
| 52 Week Low | 25.20 |
| Spread (Intraday) | 0.07 (0.25%) |
| Company Name | IDEAYA Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ideayabio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
